In mice with high-fat diet (HFD)-induced obesity, BBR administration increased GLP-1 receptor (GLP-1R) and orexin A expression while decreasing brain neuropeptide Y (NPY) expression, leading to reductions in body weight, plasma lipid levels, and insulin resistance. Here, NPY is linked to obesity disorder.